Cancer Family
Malignant Soft Tissue Neoplasm
CI-CAN-00000251Explore in graph →
341 active trials9 approved drugs37 evidence items
- NCIt
- C4867
Loading cancer entity…
Cancer Family
CI-CAN-00000251Explore in graph →
Clinical trials
1,396 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (200)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05979493 | QL Block in Laparoscopic Myomectomy | recruiting | Phase 4 | 80 | Joseph Findley MDOTHER | 1 | Sep 11, 2026 | clinicaltrials |
| NCT06143631 | Prescription of Letrozole for Uterine Myoma(PLUM) | recruiting | Phase 4 | 140 | University of California, San FranciscoOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT07664956 |
| Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy |
| not yet recruiting |
| Phase 4 |
| 36 |
| Christiana Care Health ServicesOTHER |
| 1 |
| Jun 24, 2026 |
| clinicaltrials |
| NCT07286188 | Effect of Misoprostol on Fluid Deficit Volume in Hysteroscopic Myomectomy | recruiting | Phase 4 | 40 | Northwestern UniversityOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT03244020 | LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology | enrolling by invitation | Phase 4 | 2,868 | Massachusetts General HospitalOTHER | 1 | Oct 3, 2025 | clinicaltrials |
| NCT06640738 | Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation | not yet recruiting | Phase 4 | 60 | Kaohsiung Medical UniversityOTHER | 0 | Oct 15, 2024 | clinicaltrials |
| NCT06506838 | Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma | recruiting | Phase 4 | 39 | Guangdong Provincial People's HospitalOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT05844813 | Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma(NATARS) | enrolling by invitation | Phase 4 | 102 | Peking University International HospitalOTHER | 1 | May 12, 2023 | clinicaltrials |
Data updated 18 days agoSource updated Sep 11, 2026source: clinicaltrials